Online Program

Improving Pregnancy Outcomes: Behavioral and Medical Risk Factors

Wednesday, November 4, 2015: 12:30 p.m. - 2:00 p.m.
The purpose of this session is to highlight behavioral and medical risk factors related to poor and suboptimal pregnancy outcomes. Specifically, this session will discuss the implications of cannabis use during pregnancy on maternal and fetal outcomes, maternal diabetes as a contributing factor to fetal and infant death, and medical treatment factors related to having an unplanned cesarean delivery at first childbirth. Lastly, one presentation describes partnering with pharmacists to provide preconception care as an under-utilized resource and innovative strategy to improve pregnancy outcomes.
Session Objectives: Participants in this session will be able to: 1) Describe behavioral and medical risk factors for adverse perinatal outcomes associated with cannabis use, cigarette smoking, diabetes, and medical interventions 2) Identify ways in which pharmacists can be valuable members of the perinatal health team for promoting optimal pregnancy outcomes
Tyan Parker Dominguez, PhD, MPH, MSW and Christina Ratleff, MPH

Effects of prenatal cannabis exposure on fetal development and pregnancy outcomes: A systematic review and meta-analysis   
Jayleen Gunn, PhD, MPH, Katherine Center, PhD, John Ehiri, PhD, Annabelle V. Nunez, Cecilia Rosales, MD, MS and Steven Gibson, B.S.
Diabetes in pregnancy: The other silent killer   
Anne Lise Musselman, RN, BSN, MA, Charles William Allen, MD, Teri Conard, RN, BSN, MN and Yvonne Beasley, RN, MN

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Maternal and Child Health
Endorsed by: Aging & Public Health, Women's Caucus, Alcohol, Tobacco, and Other Drugs, APHA-Committee on Women's Rights

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)